Jongbok M. Lee

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Clinical evidence for immune cell-based therapy for head and neck cancer: A systematic review and meta-analysis.

Clinical evidence for immune cell-based therapy for head and neck cancer: A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: May 04, 2026

Development and computational analysis of high dimensional spectral flow cytometry data for the resolution of innate lymphoid cells in the mammary tumor microenvironment.

Development and computational analysis of high dimensional spectral flow cytometry data for the resolution of innate lymphoid cells in the mammary tumor microenvironment.

Journal: Frontiers in immunology

Published: October 22, 2025

Adoptive Cellular Therapies in Pediatric Leukemia Patients After Allogeneic-Hematopoietic Stem Cell Transplants.

Adoptive Cellular Therapies in Pediatric Leukemia Patients After Allogeneic-Hematopoietic Stem Cell Transplants.

Journal: Immune network

Published: June 18, 2025

Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapy.

Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapy.

Journal: Journal for immunotherapy of cancer

Published: April 02, 2025

Allogeneic double-negative T-cell therapy for acute myeloid leukemia.

Allogeneic double-negative T-cell therapy for acute myeloid leukemia.

Journal: Current opinion in pharmacology

Published: September 01, 2024

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD.

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 28, 2024

SOCS1 Protects Acute Myeloid Leukemia against Allogeneic T Cell-Mediated Cytotoxicity.

SOCS1 Protects Acute Myeloid Leukemia against Allogeneic T Cell-Mediated Cytotoxicity.

Journal: Blood cancer discovery

Published: June 06, 2024

Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing.

Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing.

Journal: Haematologica

Published: June 05, 2024

Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.

Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.

Journal: Nature communications

Published: September 05, 2023

Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells.

Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells.

Journal: Journal for immunotherapy of cancer

Published: August 16, 2023

In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.

In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.

Journal: Nature communications

Published: May 06, 2022

A new longitudinal variation in the structure of collagen fibrils and its relationship to locations of mechanical damage susceptibility.

A new longitudinal variation in the structure of collagen fibrils and its relationship to locations of mechanical damage susceptibility.

Journal: Journal of the mechanical behavior of biomedical materials

Published: October 08, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026